- $24.8 BnWorld market, 2023
- $39.3 BnProjected, 2033
- 4.7%Growth a year (CAGR)
- 4,004Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$10.4 Bn
2.7% a year · 42% of the world -
2
China
$2 Bn
6.2% a year · 8% of the world -
3
Canada
$2 Bn
4.7% a year · 8% of the world -
4
Japan
$1.5 Bn
5.2% a year · 6.2% of the world -
5
Germany
$908 Mn
2.9% a year · 3.7% of the world -
6
France
$682 Mn
3.7% a year · 2.8% of the world -
7
UK
$645 Mn
2.7% a year · 2.6% of the world -
8
Brazil
$620 Mn
5.7% a year · 2.5% of the world -
9
Italy
$595 Mn
4.2% a year · 2.4% of the world -
10
Ecuador
$496 Mn
5.3% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainCancer Supportive Care Drugs by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 9,993 papers since 2021
- Disparities in Treatment Patterns for Advanced ALK- and EGFR-Mutated Non-Small Cell Lung Cancer Patients in Mexico. Thoracic cancer, 2026
- Differences in end-of-life caregiving experiences among bereaved family members of patients who died from cancer or dementia: a nationwide mortality follow-back survey in Japan. BMJ supportive & palliative care, 2026
- Comparison of quality of life between docetaxel and weekly paclitaxel in the neoadjuvant or adjuvant treatment of breast cancer. Oncology, 2026
- Association of HTR3A and COMT polymorphisms with electroacupuncture response for chemotherapy-induced nausea and vomiting in breast cancer: a secondary analysis of a randomized controlled trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026
- Spiritual beliefs and preferences among patients with multiple myeloma. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026
Compare Cancer Supportive Care Drugs side by side
Quick answers
How big is the Cancer Supportive Care Drugs market?
The world Cancer Supportive Care Drugs market was worth about $24.8 Bn in 2023 and is projected to reach $39.3 Bn by 2033, growing 4.7% a year (CAGR).
Which country has the largest Cancer Supportive Care Drugs market?
The US is the largest of the 24 countries we cover, at $10.4 Bn in 2023. India grows fastest, at 7.7% a year.
How many clinical trials are running in Cancer Supportive Care Drugs?
ClinicalTrials.gov lists 4,004 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Cancer Supportive Care Drugs?
PubMed lists about 9,993 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.